Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-029176
Filing Date
2015-03-25
Accepted
2015-03-25 16:05:12
Documents
1
Period of Report
2015-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4026
  Complete submission text file 0001209191-15-029176.txt   5473
Mailing Address 65 HAYDEN AVE LEXINGTON MA 02421
Business Address
GUIFFRE CHRISTOPHERD T (Reporting) CIK: 0001219021 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 15724772

Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Issuer) CIK: 0001401914 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations